N@N

Impact Fusion International Inc.: Impact Fusion International Provides Update

^{Published on 2009-05-13 06:42:51, Last Modified on 2009-05-13 06:43:59 - Market Wire}
 

DEERFIELD BEACH, FLORIDA--(Marketwire - May 13, 2009) - Impact Fusion International Inc. (PINK SHEETS:RRLB) (formerly Red Reef Laboratories International Inc.) announced today that it has applied for a new trading symbol and approval for the name change as required by FINRA. The Company has been assigned a new CUSIP.

Management is currently conducting a thorough review of all core products to be sold under the Intact Natural Nutrition Brand and the company's wholly owned subsidiary, Myotrend Nutritional Technologies, LLC. All products to appear under these brand headings will now feature the unique and patented Nutra-Mastic minerals delivery system. The Company has several initiatives underway including packaging and labelling redesign, marketing and sales strategies including representative distribution and e-Commerce capabilities, corporate supply-chain and customer order fulfillment. Several formulations under both brand headings are market tested and ready for launch.

In addition, the Company is conducting a review and restructuring of all other remaining product and brands of Red Reef Laboratories International, Inc., to operate under the Louisiana subsidiary, RR Louisiana Property, LLC. This reorganization will be followed by a name change of that subsidiary and a management staff dedicated to the development of "Green Technologies" and renewable energy.

"As part of our overall development strategy, we are interviewing to fill the position of Chief Financial Officer. Our primary goal will be to bring all of our filings up to date with a view to submitting a Form 10 within the next 90 days to become fully reporting." stated Peter Versace, President.

"A new Advisory Board is being formed to seek input regarding corporate governance, marketing strategies, distribution, new product development and product launch." said Mr. Versace.

About Impact Fusion International Inc.

Impact Fusion International, Inc is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well being of Humans and Animals including, yet not limited to, aids for digestive health, optimum liver and kidney functions, healthy blood cells, proper blood pressure and blood sugar levels and reducing the negative side effects for patients undergoing chemotherapy treatment. Management will target a list of products that will be developed into revenue producing, profitable brand sectors utilizing investment capital and other resources including management, patent development and strategic planning for the benefit of these individual brands. Impact Fusion International, Inc. owns patent technologies that are the core ingredients in all of our products. The patent pending was established in 2005 after many years of research and development. What we have discovered is that our proprietary blending of Mastic Gum with ionic minerals enables the Mastic gum and its many therapeutic uses to be delivered directly into the blood system because of the positive and negative charge of the ionic minerals. The unique NutriMastic delivery system alone or when combined with other essential ingredients creates a host of healthy benefits to the body which in turn enhances the total functionality of the body's interactive systems.

This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.